Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.90 | 4.57 |
| PEG Ratio (TTM) | 0.03 | 0.98 |
| P/S Ratio (TTM) | 0.73 | 1.36 |
| P/B Ratio (TTM) | 6.14 | 2.19 |
| P/FCF Ratio (TTM) | -0.80 | 17.43 |
| Price to 5YR AVG Earnings Ratio | N/A | -95.08 |
| Price to 5YR AVG FCF Ratio | N/A | 16.86 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -65.40% | 1.06% |
| ROE (TTM) | -226.92% | 16.81% |
| Net Profit Margin (TTM) | -82.52% | 1.64% |
| ROIC 5YR AVG | N/A | 18.43% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | 325.20% | N/A |
| Revenue | N/A | -2.96% | N/A |
| Net Income | N/A | 260.37% | N/A |
| Cash Flow | N/A | -139.17% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.76 | 1.21 |
| Quick Ratio (TTM) | 1.76 | 1.17 |
| D/E Ratio (TTM) | 0.84 | 1.01 |
| Interest Coverage (TTM) | -19.10 | 3.98 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 2.15 |
| LTL to 5YR AVG FCF | N/A | 5.41 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.81% |